Published in BMC Neurosci on March 03, 2010
The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol Sci (2011) 0.97
Current primary open-angle glaucoma treatments and future directions. Clin Ophthalmol (2012) 0.93
Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors. Neuroscience (2013) 0.90
Atoh7 promotes the differentiation of retinal stem cells derived from Müller cells into retinal ganglion cells by inhibiting Notch signaling. Stem Cell Res Ther (2013) 0.87
Neuroprotection in Glaucoma. J Ophthalmic Vis Res (2016) 0.86
Effects of Rhein lysinate on H2O2-induced cellular senescence of human umbilical vascular endothelial cells. Acta Pharmacol Sin (2011) 0.86
Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina. Int J Mol Sci (2014) 0.85
A case for neuroprotection in ophthalmology: developments in translational research. Mo Med (2013) 0.80
Comparison of two methods used to culture and purify rat retinal Müller cells. Int J Ophthalmol (2013) 0.78
Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools. Front Neurosci (2015) 0.77
Atoh7 promotes the differentiation of Müller cells-derived retinal stem cells into retinal ganglion cells in a rat model of glaucoma. Exp Biol Med (Maywood) (2015) 0.77
Differentiation renders susceptibility to excitotoxicity in HT22 neurons. Neural Regen Res (2013) 0.77
Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma. Neural Regen Res (2012) 0.76
Bis(7)-tacrine protects retinal ganglion cells against excitotoxicity via NMDA receptor inhibition. Int J Ophthalmol (2011) 0.76
Neuroprotective effects of C3 exoenzyme in excitotoxic retinopathy. Exp Eye Res (2014) 0.76
Protective Role of Glucagon-Like Peptide-1 Against High-Glucose-Induced Endothelial Oxidative Damage. Medicine (Baltimore) (2015) 0.75
Dose-dependent and combined effects of N-methyl-D-aspartate receptor antagonist MK-801 and nitric oxide synthase inhibitor nitro-L-arginine on the survival of retinal ganglion cells in adult hamsters. Neural Regen Res (2012) 0.75
Chloride channel protein 2 prevents glutamate-induced apoptosis in retinal ganglion cells. Iran J Basic Med Sci (2016) 0.75
TRPC6: an underlying target for human glaucoma. Int J Ophthalmol (2012) 0.75
Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro. Front Mol Neurosci (2017) 0.75
Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke (1999) 6.18
Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res (2004) 3.08
Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res (1997) 1.74
The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol (1957) 1.67
Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol (1997) 1.66
Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol (1993) 1.65
Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol (1996) 1.64
Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A (1999) 1.54
Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am (2005) 1.47
Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope. Pharmacol Res (2005) 1.28
Glutamate receptors and circuits in the vertebrate retina. Prog Retin Eye Res (1999) 1.23
Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Eur J Neurosci (2006) 1.22
Neuroprotection: extrapolating from neurologic diseases to the eye. Am J Ophthalmol (2009) 1.20
Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease. J Biol Chem (1996) 1.17
Pigment epithelium-derived factor protects retinal ganglion cells. BMC Neurosci (2007) 1.17
Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis. Brain Res (2008) 1.16
Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci (1998) 1.16
Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned. Acta Ophthalmol (2009) 1.09
Müller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity. Invest Ophthalmol Vis Sci (2000) 1.09
Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors. Neuropharmacology (2009) 1.08
Neuroprotection for acute stroke: making clinical trials work. Stroke (1999) 1.07
Retinal ganglion cells and neuroprotection for glaucoma. Surv Ophthalmol (2003) 1.06
Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage. Surv Ophthalmol (2003) 1.06
Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma. Brain Res Bull (2004) 1.05
Neuroprotective therapy. Semin Neurol (1998) 1.02
Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci (1994) 1.00
History of neuroprotection and rationale as a therapy for glaucoma. Am J Manag Care (2008) 0.99
Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels. J Neurochem (2006) 0.94
A proposed role for excitotoxicity in glaucoma. J Glaucoma (1998) 0.93
Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors. J Biol Chem (2005) 0.92
Neuroprotective effects of interleukin-6 on NMDA-induced rat retinal damage. Biochem Biophys Res Commun (2003) 0.88
Vitreous body glutamate concentration in dogs with glaucoma. Am J Vet Res (1997) 0.88
Novel anti-Alzheimer's dimer Bis(7)-cognitin: cellular and molecular mechanisms of neuroprotection through multiple targets. Neurotherapeutics (2009) 0.87
Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase. Mol Pharmacol (2007) 0.86
Protective effect of arachidonic acid on glutamate neurotoxicity in rat retinal ganglion cells. Invest Ophthalmol Vis Sci (2002) 0.85
Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE. Neuroreport (1999) 0.84
Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers. Neurochem Res (2002) 0.83
The mechanism by which NBQX enhances NMDA currents in retinal ganglion cells. Brain Res (1996) 0.83
Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors. Biochem Biophys Res Commun (2008) 0.83
Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studies. Neuropharmacology (2008) 0.83
Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A-induced deficits in navigational memory in rats. Neurosci Lett (2000) 0.82
Bis(7)-tacrine, a promising anti-Alzheimer's dimer, affords dose- and time-dependent neuroprotection against transient focal cerebral ischemia. Neurosci Lett (2008) 0.81
Direct inhibition of N-methyl-D-aspartate (NMDA)-receptor function by antiglaucomatous beta-antagonists. J Pharmacol Sci (2008) 0.79
Systemic calcium channel blockers and glaucoma. J Glaucoma (1996) 0.79
Neuroprotection via inhibition of nitric oxide synthase by bis(7)-tacrine. Neuroreport (2006) 0.79
An adenosine analogue inhibits NMDA receptor-mediated responses in bipolar cells of the rat retina. Exp Eye Res (1999) 0.79
Novel dimeric bis(7)-tacrine proton-dependently inhibits NMDA-activated currents. Biochem Biophys Res Commun (2007) 0.78
Selective and sensitive determination of bis(7)-tacrine, a high erythrocyte binding acetylcholinesterase inhibitor, in rat plasma by high-performance liquid chromatography-tandem mass spectrometry. Biomed Chromatogr (2008) 0.77
Development of a high performance liquid chromatography-tandem mass method for determination of bis(7)-tacrine, a promising anti-Alzheimer's dimer, in rat blood. J Pharm Biomed Anal (2007) 0.77
Displaced amacrine cells in the ganglion cell layer of the hamster retina. Vision Res (1987) 0.77